# Evidence Confirm Productionization Release Boundary Residual Routing

Verdict token:

`RELEASE_BOUNDARY_RESIDUAL_ROUTING_NOT_READY`

## Scope

Gate: `Evidence Confirm Productionization Release Boundary / Residual Routing Gate`.

This artifact routes residual work after PR-40 merge. It does not change code, run live/provider/PDF commands, tag, release, push, mutate PR state, or promote release/readiness.

## Current Accepted External Fact

- PR-40 is `MERGED`.
- PR head: `032c059fcafec1a84e8bea0aacaab613c83c2b70`
- Merge commit: `cfd845b84a9a639f112e92dc5ca49bdaebabd463`
- Tag/release were not performed.
- Release/readiness remains `NOT_READY`.

## Objective Mapping

| Objective requirement | Current evidence | State |
|---|---|---|
| Claims can be tied to disclosed annual-report evidence before user-visible output. | Default product `fund-analysis analyze` runs repository-bounded Evidence Confirm with `warn`; RR-S2 proves the five-sample source/PDF pathway through `FundDocumentRepository`; RR-S7 docs/control sync records current behavior. | Partially satisfied for default `analyze`; not release-ready because product CLI EC residuals remain. |
| Evidence Confirm can classify support as `entailed`, `contradicted`, or `insufficient`. | RR-S3 provider-backed semantic adapter evidence returned expected closed statuses; deterministic V2 remains authoritative. | Enhanced path proven as bounded evidence only; provider-backed semantic default-on production use remains a separate gate. |
| Audit results enter executable quality gate. | ECQ0-ECQ4 projection and CLI safe summary were accepted in prior productionization/default-on gates; RR-S5 proves annual-period CLI summary display. | Satisfied for accepted product surfaces except checklist and report body. |
| Default product chain is usable. | Product `analyze` defaults to repository-bounded Evidence Confirm `warn`; annual-period inherits current-year summary; checklist remains `off`. | Partially satisfied; checklist support is deferred with owner. |
| Release is supported by stable audit closure. | PR-40 merged and post-merge sync is recorded. | Not satisfied; release/readiness remains `NOT_READY`. |

## Residual Classification

| Residual | Class | Owner | Destination |
|---|---|---|---|
| Product CLI deterministic Evidence Confirm status is `fail` for four emitted RR-S2 samples under `warn` policy. | material release blocker | Evidence Confirm owner / quality gate owner / controller | `RR-09 Product CLI Evidence Confirm Fail Residual Disposition Gate` |
| `017641 / 2024` exits before Evidence Confirm summary because full product `analyze` is blocked by quality gate. | material release blocker | Quality gate owner / QDII product owner / controller | `RR-09 Product CLI Evidence Confirm Fail Residual Disposition Gate` |
| Checklist Evidence Confirm support remains explicitly deferred. | deferred with owner | Product owner / Service-CLI owner / controller | Future checklist Evidence Confirm product semantics gate |
| Report-body Evidence Confirm rendering remains explicitly outside this release. | deferred with owner | Product owner / renderer owner / controller | Future report-body Evidence Confirm UX / audit-contract gate |
| Provider-backed semantic default-on production use remains unaccepted. | deferred with owner | Provider semantic owner / controller | Future provider-backed semantic production policy gate |
| Release/tag/readiness promotion remains unauthorized. | external-state boundary | Release owner / controller | Separate release authorization after readiness evidence passes |

## Routing Decision

The next mainline gate should not be tag or release.

The next mainline gate should be:

`RR-09 - Product CLI Evidence Confirm Fail / Quality-gate Residual Disposition Gate`

Reason:

- It is closest to the final objective: claims, numbers, and conclusions must be checked before user-visible output.
- It targets the current default product `analyze` path, not an optional surface.
- RR-S2 already proved the repository source/PDF pathway; the remaining default-product uncertainty is whether current EC `fail` summaries under `warn` and the `017641 / 2024` quality-gate block are acceptable release residuals, require code fixes, or require additional evidence.
- Checklist and report-body support are intentionally deferred with owners; they should not block this routing unless product owner changes the release scope.

## RR-09 Minimum Acceptance Criteria

RR-09 must produce one of the following accepted outcomes:

1. A reviewed disposition that current product CLI EC `fail` under `warn` is acceptable for release with explicit user-facing semantics and owner.
2. A scoped implementation/fix that reduces false EC failures or fixes projection/source-evidence defects, with regression tests.
3. A scoped quality-gate/QDII disposition or fix for `017641 / 2024`.
4. A reviewed decision that release remains blocked and routes to a narrower field/evidence extraction gate.

RR-09 must not:

- bypass `FundDocumentRepository`;
- consume raw PDF/cache/parser artifacts outside Fund documents internals;
- switch provider-backed semantic to default production use;
- add checklist Evidence Confirm support;
- add report-body Evidence Confirm rendering;
- tag, release, or claim readiness.

## Validation

- Read post-merge artifact `docs/reviews/evidence-confirm-productionization-release-readiness-post-merge-control-sync-20260623.md`.
- Read RR-S2 evidence artifact `docs/reviews/evidence-confirm-productionization-release-readiness-rr-s2-live-source-pdf-evidence-20260623.md`.
- Read RR-S4 checklist deferral artifact `docs/reviews/evidence-confirm-productionization-release-readiness-rr-s4-checklist-deferral-20260623.md`.
- Read RR-S6 report-body decision artifact `docs/reviews/evidence-confirm-productionization-release-readiness-rr-s6-report-body-decision-20260623.md`.

Completion token: `RELEASE_BOUNDARY_RESIDUAL_ROUTING_NOT_READY`
